...
首页> 外文期刊>Journal of Medical Case Reports >Acquired haemophilia A associated with autoimmune thyroiditis: a case report
【24h】

Acquired haemophilia A associated with autoimmune thyroiditis: a case report

机译:获得性甲型血友病伴自身免疫性甲状腺炎:一例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Acquired haemophilia A is a rare life- and limb-threatening bleeding disorder if left untreated. Autoimmune thyroiditis is an autoimmune disorder that can be rarely associated with acquired haemophilia. Here we report a case of a 60-year-old woman presenting with cutaneous and muscle haematomas secondary to acquired haemophilia A in association with autoimmune thyroiditis, who was successfully treated with recombinant activated factor VII and immunosuppression. Case presentation A 60-year-old Sri Lankan woman with a background of longstanding hypothyroidism, diabetes mellitus, hypertension, hyperlipidaemia and bronchial asthma developed spontaneous cutaneous purpura and a limb-threatening intramuscular haematoma. Initial coagulation screening revealed prolonged activated partial thromboplastin time of 66.4 seconds (normal range 26 to -36 seconds) and time-dependent inhibitors against factor VIII. She had positive antinuclear antibody and antithyroid peroxidase (microsomal) antibody titre of over 1/80 and 1000IU/mL respectively. The diagnosis was therefore made of acquired haemophilia A in association with autoimmune thyroiditis. Acute limb-threatening bleeding was managed with recombinant activated factor VII (NovoSeven?). Immunosuppressive treatment consisting of oral prednisone 60mg/day and cyclophosphamide 100mg/day was administered in order to remove the factor VIII inhibitor. This treatment led to normalisation of her haemostatic parameters. This case illustrates a very rare association of acquired haemophilia and autoimmune thyroiditis as well as the importance of considering acquired haemophilia as a differential diagnosis of spontaneous bleeding. Conclusions Acquired haemophilia should be considered in the differential diagnosis of unexplained bleeding in adults. Treatment of the acute coagulopathy with recombinant activated factor VII and immunosuppressive therapy was successful in this case.
机译:简介如果不加以治疗,获得性A型血友病是一种罕见的危及生命和肢体的出血性疾病。自身免疫性甲状腺炎是一种自身免疫性疾病,很少与获得性血友病相关。在这里,我们报道了一名60岁女性,其表现为继发于获得性A型血友病并伴有自身免疫性甲状腺炎的继发于皮肤和肌肉的血肿,该患者已成功用重组激活因子VII和免疫抑制治疗。病例介绍一名60岁的斯里兰卡妇女,长期患有甲状腺功能低下,糖尿病,高血压,高血脂症和支气管哮喘,发展为自发性皮肤紫癜和威胁肢体的肌内血肿。初步的凝血筛查显示,活化的部分凝血活酶时间延长了66.4秒(正常范围是26至-36秒),并且是针对时间的因子VIII抑制剂。她的抗核抗体和抗甲状腺过氧化物酶(微粒体)抗体滴度分别超过1/80和1000IU / mL。因此,诊断是获得性A型血友病伴自身免疫性甲状腺炎。急性肢体出血可通过重组活化因子VII(NovoSeven?)处理。给予口服泼尼松60mg /天和环磷酰胺100mg /天组成的免疫抑制治疗,以去除VIII因子抑制剂。这种治疗导致她的止血参数正常化。该病例说明获得性血友病和自身免疫性甲状腺炎的罕见关联,以及将获得性血友病视为自发性出血的鉴别诊断的重要性。结论对成人原因不明的出血进行鉴别诊断时应考虑获得性血友病。在这种情况下,用重组激活因子VII和免疫抑制疗法成功治疗了急性凝血病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号